Effects of the DASH vs. the Mediterranean Diet Combined With Salt Restriction on Blood Pressure Levels in Adults
Hypertension

About this trial
This is an interventional prevention trial for Hypertension focused on measuring Hypertension, Blood pressure, Diet, Salt, Dietary Approaches to Stop Hypertension, Mediterranean, Dietary pattern
Eligibility Criteria
Inclusion Criteria: High normal BP (office systolic BP: 130-139 mmHg and/or office diastolic BP: 85-89 mmHg) or grade 1 hypertension (office systolic BP: 140-159 mmHg and/or office diastolic BP: 90-99 mmHg) and low-moderate 10-year cardiovascular disease risk. Willingness to participate in a dietary intervention to control BP and to attend individual sessions. Signed informed consent form for participation. Exclusion Criteria: Current use of anti-hypertensive medications. Current use of any other medications or agents affecting BP levels (e.g., nonsteroidal anti-inflammatory drugs). Use of food supplements accompanied by a refusal to discontinue them. Participation in a clinical study involving a drug or device within 3 months of screening. Active weight loss or participation in a weight loss treatment program within 3 months of screening. Secondary hypertension. Atomic history of cardiovascular disease (e.g. acute myocardial infarction, stroke, heart failure). Diabetes Mellitus (Type 1 & 2). Chronic kidney disease, defined as an estimated Glomerular Filtration Rate (eGFR) <60 mL/min/1.73m2. Liver disease (e.g., hepatitis, cirrhosis). Lung disease (e.g., chronic obstructive pulmonary disease). Inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis). Celiac disease. Active malignancy or cancer therapy. Current major psychiatric disorder or current drug abuse. Body Mass Index >40 kg/m2. Current alcohol consumption >14 drinks per week. Current or planned pregnancy before the end of the study, or breast-feeding. Any concomitant conditions that in the opinion of the investigator interfere with the diet or other situations requiring specific nutritional management.
Sites / Locations
- Hypertension Unit, First Cardiology Clinic, Hippocration General Hospital, National and Kapodistrian University of Athens
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
No Intervention
Experimental
Experimental
Experimental
Control Group (CG)
Salt Restriction Group (SRG)
DASH Diet combined with salt restriction Group (DDG)
Mediterranean Diet combined with salt restriction Group (MDG)
Patients continued to consume their usual diet for 3 months
Patients continued to consume their usual diet, but they restricted sodium intake to 2,000 mg/ day for 3 months.
Patients consumed the DASH diet for 3 months.
Patients consumed the MedDiet diet for 3 months.